Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative Proteomic Analysis Reveals VMG Oncolytic Virus-Induced Molecular Reprogramming in Pancreatic Ductal Adenocarcinoma.

Research square·2026
Same author

Challenge-based ex vivo immune profiling reveals stimulus-dependent peripheral immune reprogramming in Alzheimer's disease.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

Western Diet-Induced Obesity Modulates the Mammary Fat Pad Microenvironment.

Cells·2026
Same author

Flow cytometry method to identify arginase-1 expressing MDSCs.

MethodsX·2026
Same author

Association Between Severe Perioperative Surgical Morbidity With Cesarean Delivery and Postpartum Readmission.

Obstetrics and gynecology·2026
Same author

Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer.

Cells·2026

Related Experiment Video

Updated: Jul 13, 2026

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development.

Jovanny Zabaleta1, Barbara G Schneider, Kelli Ryckman

  • 1Stanley S. Scott Cancer Center, LSUHSC, New Orleans, LA, USA.

Cancer Immunology, Immunotherapy : CII
|July 10, 2007
PubMed
Summary

Genetic variations in cytokine genes, specifically single nucleotide polymorphisms (SNPs), show significant differences between African-American and Caucasian newborns. These disparities in inflammation-related SNPs may contribute to cancer incidence and mortality differences between these ethnic groups.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

Related Experiment Videos

Last Updated: Jul 13, 2026

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

Area of Science:

  • Genetics
  • Immunology
  • Cancer Research

Background:

  • Ethnic disparities in cancer incidence and outcomes suggest underlying biological and socio-economic factors.
  • Chronic inflammation, influenced by genetic variations in cytokine genes, is a potential risk factor for cancer.
  • Single nucleotide polymorphisms (SNPs) in cytokine genes can alter inflammation levels, but their ethnic-specific effects on cancer risk are not fully understood.

Purpose of the Study:

  • To investigate ethnic differences in the frequencies of specific cytokine gene polymorphisms between African-American and Caucasian newborns.
  • To explore the potential role of these genetic variations in explaining cancer disparities.

Main Methods:

  • Genotyping of seven specific cytokine polymorphisms (IL1B, IL1RN, IL10, TNF) in newborns from Louisiana.
  • Comparison of allelic frequencies and linkage disequilibrium patterns between African-American (n=294) and Caucasian (n=299) infant groups.

Main Results:

  • Significant differences in the frequencies of multiple cytokine SNPs (IL1B-511, IL1B-31, IL10-1082, IL10-592) were observed between the two ethnic groups.
  • Distinct linkage disequilibrium patterns were found for IL1B polymorphisms in each group.
  • Allelic frequencies for IL1B + 3954, IL1RN*2, and TNF-308 differed significantly between African-American and Caucasian newborns.

Conclusions:

  • Observed ethnic-specific differences in cytokine gene polymorphisms suggest variations in inflammatory response.
  • These genetic dissimilarities may contribute to the observed disparities in cancer incidence and mortality between African-Americans and Caucasians.